The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent years witnessing several important controversies. In July 2022, Science magazine reported that a key 2006 research paper, published in the prestigious journal Nature , which identified a subtype of brain protein called beta-amyloid as the cause of Alzheimer's, may have been based on fabricated data. One year earlier, in June 2021, the US Food and Drug Administration had